The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
2688 results found
In 2022, working with its Health Research Impact Committee, National Health and Medical Research Council (NHMRC) developed the NHMRC Research Translation Strategy 2022–2025.
MRFF and NHMRC – Clinical Trials Activity Initiative – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Grant Opportunity
A major achievement for Associate Professor Shannon Simpson was the recent establishment of PELICAN (Prematurity’s Effects on the Lungs In Children and Adults Network), which she co-chairs with Dr Jenny Hallberg from the Karolinska Institute in Sweden.
Dr Jeffrey Liddell from the University of Melbourne is a mid-career neurobiologist, with an interest in neurodegenerative diseases and understanding their underlying causes.
Australia’s National Health and Medical Research Council (NHMRC) has launched the 12th edition of 10 of the Best, showcasing significant projects that support the improvement of human health.
Members of the Council of National Health and Medical Research Council (NHMRC), 1 July 2021 to 30 June 2024.
Members of the 2021–2024 Research Committee of the National Health and Medical Research Council (NHMRC) are appointed until 30 June 2024.
Hysterectomy is the most common major gynaecological procedure Australian women will require in their lifetimes. Yet, up to 2 in 10 patients have developed severe complications following outdated open surgery.
As a practising optometrist, Associate Professor Zhichao Wu realised there was a big problem diagnosing glaucoma. Glaucoma is a leading cause of irreversible vision loss that is projected to cost Australia $4.3 billion per annum by 2025.
Australia, like many other countries, is facing increasing rates of mental disorders and substance use. Globally, substance use, depression and anxiety disorders are among the leading causes of disease burden in young people. Yet they are treated in isolation, stalling discovery, prevention and treatment.
The Research Involving Human Embryos Act 2002 requires that research on human embryos can only be conducted under a licence issued by the National Health and Medical Research Council (NHMRC) Embryo Research Licensing Committee (NHMRC Licensing Committee).
There are 2 Commonwealth Acts providing a regulatory framework to prohibit certain unacceptable practices including human cloning, and to regulate uses of excess human embryos created through assisted reproductive technology.
Licence holders are responsible for ensuring that their organisations comply with licence conditions. Each person who is identified in the licence conditions as an authorised person must be fully informed about the licence and its conditions and the requirements of the legislation and any corresponding state or territory law.
Organ and tissue transplantation is an effective and well-established treatment, with the potential to drastically improve the health and life of recipients. However, despite increasing success rates and the broadening of recipient eligibility and organ suitability criteria, the demand for organs and tissues continues to exceed their availability.
Section 19(3) of the Research Involving Human Embryos Act 2002 (the Act) requires the NHMRC Licensing Committee to table six-monthly reports in either House of Parliament on or before 30 June and 31 December each year, and at any other time as required by either House of Parliament. The reports must include information about both the operation of the Act and licences issued under the Act.